from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1744c/-

LFCtreatmentdescriptionclass of inhibitor

0.299

Amikacinug/mL Amikacintranslation

0.026

Cap5-10ug/mL Capreomycintranslation

-0.071

Rox10-50 ug/mL Roxithromycintranslation

-0.247

SM2-5 ug/mL Streptomycintranslation

-0.559

Tet5-10 ug/mL Tetracyclinetranslation

-0.145

Rif0.2-5ug/mL Rifampicintranscription

0.368

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.713

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.136

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.420

CPZ10-50 ug/mL Chlorpromazinerespiration

0.012

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.375

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.296

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.022

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.690

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.425

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.590

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.206

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.111

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.296

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.556

KCN5-20 ug/mL Potassium cyaniderespiration

-0.496

NaN30.2-2 mM Sodium aziderespiration

-1.808

Nigericin50 uM Nigericinrespiration

0.898

TRC10-150 ug/mL Triclosanrespiration

1.148

TRZ10-25 ug/mL Thioridazinerespiration

-1.044

Valinomycin0.5-10 uM Valinomycinrespiration

-1.830

ZnSO42 mM ZnSO4respiration

-0.618

menadione6-10 ug/mL Menadionerespiration

0.619

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.279

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.726

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.183

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.451

NRP_1Non-replicating persistence stage 1dosRassociated

-0.340

Amp0.2mg/mL AmpicillincellWall

-0.342

Cephalexin20-100 ug/mL CephalexincellWall

-0.347

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.292

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.524

EMB10-20 ug/mL EthambutolcellWall

-0.600

Eta12-40 ug/mL EthionamidecellWall

-0.795

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.043

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.664

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.956

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.025

BZA0.12 mg/mL BenzamidearomaticAmides

-0.029

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.253

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.090

H2O24 mM hydrogen peroxideDNAdamaging

0.266

Levo10 ug/mL LevofloxacinDNAdamaging

0.298

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.008

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.090

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.431

UVUV-irradiationDNAdamaging

1.214

ARP41-4 ug/mL Antitubercular compound ARP4?

0.729

Antimycin12.5-50 ug/mL Antimycin A?

-0.081

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.266

PA_110-50 ug/mL Antitubercular compound PA-1?

0.393

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.475

PA8240.2-2 ug/mL PA-824?

0.522

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.488

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.162

Verapamil50 uM Verapamil?

-0.737

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.408

methoxatin10-20 ug/mL Methoxatin?